Product

BI 474121

Aliases

10 milligram (mg) BI 474121, 20 milligram (mg) BI 474121, 2.5 milligram (mg) BI 474121, 40 milligram (mg) BI 474121 (2 other aliases)

5 clinical trials

1 indication

Indication

Clinical trial

Effect of Itraconazole on the Pharmacokinetics of a Single Oral Dose of BI 474121 in Healthy Male Subjects (an Open-label, Two-period Fixed Sequence Design Study)

Status: Completed, Estimated PCD: 2021-04-01

Clinical trial

Pharmacokinetics and Pharmacodynamic Effects of Different Single Oral Doses of BI 474121 in Healthy Male Subjects

Status: Completed, Estimated PCD: 2021-07-01

Clinical trial

A Randomised, Single-blind, Placebo-controlled Trial to Investigate Safety, Tolerability, and Pharmacokinetics of Single Rising Oral Doses of BI 474121 Administered as Oral Solution and Tablets to Healthy Male Subjects (SRD Part), and a Randomised, Open-label, Single-dose, Three-way Cross-over Bioavailability Comparison of BI 474121 as Tablet Versus Oral Solution and Tablet With and Without Food (BA Part)

Status: Completed, Estimated PCD: 2021-03-25

Clinical trial

Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 474121 in Young and Elderly Healthy Male and Female Subjects (Double-blind, Randomised, Placebo-controlled, Parallel Group Design) and Evaluation of Midazolam Interaction in Young Healthy Male and Female Subjects (Nested, Open, Fixed-sequence, Intra-individual Comparison)

Status: Completed, Estimated PCD: 2021-10-07

Clinical trial

Safety, Tolerability, and Pharmacokinetics of Single Rising Oral Doses of BI 474121 in Healthy Japanese Male Subjects (Doubleblind, Randomised, Placebo-controlled, Parallel Group Design)

Status: Completed, Estimated PCD: 2021-11-11